Radiation Oncology·Chicago, IL

University of Chicago/University of Illinois College of Medicine at Chicago

Signal lift53%75%+22 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
229–265
p10 – p90
Sample N
178
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
1.7%
3 of 178 applicants
01Cohort funnelthis cycle
N = 178
Applied
178
100.0%
Invited
67
37.6%
Class size
3
1.7%
J-1 visaH-1B visaF-1 visaAdvanced
Your fitUniversity of Chicago/University of Illinois College of Medicine at Chicago Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at University of Chicago

Create free account

Who to contact

Training sites2 hospitals · Chicago
  • 1
    University of Chicago Medical Center
    Chicago, IL
    Primary
  • 2
    University of Illinois Hospital and Clinics
    Chicago, IL
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK229 – 265
180205230255280

Level 2 CE data not available

Interview rates
US MD
56%
US DO
19%
US IMG
6%
Non-US IMG
3%
Applicant origin
In-state
89%
Out-of-state
35%
Interview prepRadiation Oncology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesRadiation Oncology · 25-26
Save this program

Add University of Chicago/University of Illinois College of Medicine at Chicago to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiation Oncology.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.